Polydatin Inhibits Neuroinflammation in Cerebral Ischemia–Reperfusion Injury Through Suppressing the CXCL3 / CXCR2 Axis
CNS Neuroscience & Therapeutics · 2026-05 · 32 (5)
DOI: 10.1002/cns.70947 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 23.05.2026. Verfasst von Youxiang Cui und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Cangzhou, China. Hauptthemen laut MEDLINE: Glucosides, Stilbenes, Reperfusion Injury, Receptors, Interleukin-8B. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Natural Science Foundation, the National Natural Science Foundation of China, Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
Aim
The aim of this study is to investigate the precise mechanisms by which Polydatin (PD) ameliorates cerebral ischemia–reperfusion injury (CIRI).
Methods
We first established a rat model of CIRI to evaluate PD's therapeutic effects. Transcriptomic analysis was used to explore PD's impact on gene expression in ischemic brain tissue of CIRI rats. OGD/R‐induced microglial activation experiments validated that PD inhibits microglial activation by targeting the CXCL3/CXCR2 axis.
Results
PD intervention improved neurological function scores of CIRI rats, reduced infarct area, alleviated pathological damage, and preserved Nissl bodies in brain tissue. It also modulated oxidative stress levels. Transcriptomic analysis showed enrichment of the Cytokine–cytokine receptor interaction pathway and several inflammatory pathways after PD intervention, with downregulation of CXCL3 and CXCR2. PD decreased pro‐inflammatory cytokine levels and CXCL3/CXCR2 protein expression in ischemic brain tissue of CIRI rats, and reduced positive expression areas of IBA1 + CXCL3 + , IBA1 + CXCR2 + , and MPO + CXCR2 + . In vitro experiments demonstrated that PD reduced pro‐inflammatory cytokine levels in BV2 cell supernatants treated with OGD/R and inhibited BV2 cell migration. However, these effects were abolished when treated with CXCL3 neutralizing antibody and SiCXCR2.
Conclusion
Our findings suggest that PD can inhibit microglial migration and activation by acting on the CXCL3/CXCR2 axis, thereby alleviating the inflammatory response in CIRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Cangzhou, China.
- Key Laboratory of Neurological Rehabilitation, Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Cangzhou, China.
- Qingxian Hospital of Traditional Chinese Medicine, Cangzhou, China.
- Huanghua Hospital of Traditional Chinese Medicine, Huanghua, China.
- Nantong Hospital of Traditional Chinese Medicine, Nantong, China.
- Tianjin University of Traditional Chinese Medicine, Tianjin, China.
ORCID-Profile: Ning Wang, Yuhong Bian, Shuquan Lv, Huantian Cui
Förderung
- Hebei Natural Science Foundation
- the National Natural Science Foundation of China
- Natural Science Foundation of Hebei Province
Zitieren
APA
Cui, Y., Hu, F., Wang, S., Liu, Z., Chen, J., Cui, M., Wang, L., Wang, Y., Wang, N., Bian, Y., Lv, S., & Cui, H. (2026). Polydatin Inhibits Neuroinflammation in Cerebral Ischemia–Reperfusion Injury Through Suppressing the CXCL3 / CXCR2 Axis. CNS Neuroscience & Therapeutics, 32(5). https://doi.org/10.1002/cns.70947
Vancouver
Cui Y, Hu F, Wang S, Liu Z, Chen J, Cui M, et al. Polydatin Inhibits Neuroinflammation in Cerebral Ischemia–Reperfusion Injury Through Suppressing the CXCL3 / CXCR2 Axis. CNS Neuroscience & Therapeutics. 2026;32(5). doi:10.1002/cns.70947
BibTeX
@article{Cui2026,
author = {Cui, Youxiang and Hu, Fangmei and Wang, Shixin and Liu, Zehua and Chen, Jinzhou and Cui, Mingyue and Wang, Leilei and Wang, Yuming and Wang, Ning and Bian, Yuhong and Lv, Shuquan and Cui, Huantian},
title = {Polydatin Inhibits Neuroinflammation in Cerebral Ischemia–Reperfusion Injury Through Suppressing the CXCL3 / CXCR2 Axis},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {5},
doi = {10.1002/cns.70947}
}
EUVIMED